Coronary artery calcium score.
By: Polonsky TS, Blumenthal RS, Greenland P.
Read on Pubmed
Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile.
By: Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR.
This study sought to develop a new method for calculating low-density lipoprotein cholesterol, the so-called “bad” form of blood fat that can lead to hardening of the arteries, that would be more accurate than the standard profile for measuring a person’s risk for heart attack and stroke.
Read on Pubmed
Statin therapy for hyperlipidemia.
By: McEvoy JW, Blumenthal RS, Blaha MJ.
Read on Pubmed
The role of echocardiography for cardiovascular risk assessment of the asymptomatic individual.
By: Michos ED, Abraham TP.
Read on Pubmed
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
By: Hare JM, Fishman JE, Gerstenblith G, et al.
This study showed that, in aggregate, an injection of mesenchymal stem cells as a therapy for patients with ischemic cardiomyopathy favorably affected their functional capacity, quality of life, and ventricular remodeling.
Read on Pubmed
Lipid parameters and cardiovascular events in patients taking statins.
By: Martin SS, Jones SR.
Read on Pubmed
Statin therapy for healthy men identified as “increased risk.”
By: Blaha MJ, Nasir K, Blumenthal RS.
In this featured debate in JAMA, we reviewed the extensive data from randomized clinical trials and observational studies supporting the selective use of lipid lowering therapy in a middle-aged man with hyperlipidemia.
Read on Pubmed
Statin therapy dose and risk of new-onset diabetes.
By: McEvoy JW.
Read on Pubmed
